The acid-labile subunit (ALS) is an approximately 85 kDa N-glycoprotein that is known primarily as a component of the systemic insulin-like growth factor-binding protein (IGFBP) complex. We have amplified, using a PCR, three overlapping porcine ALS genomic DNA fragments that together encode the distal region of the signal peptide through to the COOH-terminus. The compiled sequence of 1775 nucleotides of the three overlapping DNAs and the deduced amino acid sequence of the mature porcine ALS (pALS) protein exhibited 84/81%, 79/77%, 79/78% and 84/79% identities with respect to those of the human, the rat, the mouse and the baboon respectively. Four conserved cysteine residues in the NH 2 -terminal domain and 20 leucine-rich repeats in the central domain also were identified at identical positions in the porcine ALS. By using Northern blot analysis, with a genomic DNA fragment as the probe, it was determined that a 2·2 kb ALS mRNA was induced in the liver during the late fetal stage, and hepatic ALS mRNA abundance was increased post-natally. Moreover, hepatic ALS mRNA abundance was increased by daily injection of porcine somatotropin (100 µg/kg body weight) in cross-bred market pigs each weighing approximately 100 kg. The ALS mRNA was not detected by Northern analysis in any non-hepatic tissue examined. However, results of a more sensitive solution hybridization/RNAse protection assay indicated that low levels of ALS mRNA were also present in adult muscle, spleen, ovary and uterus, but not in lung, kidney, oviduct and placenta. Taken together, the present results suggest that although liver is the primary organ that expresses the ALS gene under somatotropin stimulation, some non-hepatic tissues also express the gene at low levels in the pig.
INTRODUCTION
Insulin-like growth factor (IGF)-I and IGF-II in biological fluids are almost invariably bound to one of the six known IGF-binding proteins (IGFBPs) (Jones & Clemmons 1995 , Rechler & Clemmons 1998 , Simmen et al. 1998 , Hwa et al. 1999 . The acid-labile subunit (ALS) is an approximately 85 kDa N-glycosylated protein that is associated with IGFBP-3:IGF or IGFBP-5:IGF binary complexes, primarily with the former, forming 120-150 kDa ternary complexes (Baxter et al. 1989 , Holman & Baxter 1996 , Twigg & Baxter 1998 , although ALS:IGFBP-3 binary complexes also can be formed in vitro with reduced avidity (Barreca et al. 1995 , Lee & Rechler 1995a ). This protein is composed largely of 20 tandem leucine-rich repeats (LRRs) of 24 amino acids (Leong et al. 1992) , which are known to be involved in protein-protein interactions (Kobe & Deisenhofer 1995) . Recently, the 20 LRRs of the human ALS (hALS) have been predicted, by computer modeling and by rotary shadowing and electron microscopy, to form a donut-shaped structure, its internal face potentially interacting with IGFBP-3 (Janosi et al. 1999) .
ALS is primarily a plasma protein, although there also is evidence indicating that this protein is present in non-vascular fluids as well (Simmen et al. 1988 , Davis et al. 1992 , Xu et al. 1995 , Khosravi et al. 1997 , Whellams et al. 2000 . In plasma, ALS serves as a reservoir of systemic IGFs by restricting the majority of these within the ternary complexes from which the IGF is slowly released, principally after limited proteolysis of IGFBP-3 within the complex (Blat et al. 1994 , Jones & Clemmons 1995 , Lee & Rechler 1995b , 1996 . The ALS complex may also enhance overall body growth by maximizing the bioavailability of systemic IGFs; this is supported by the results of Ueki et al. (2000) , who reported that mice with a disrupted ALS gene had reduced serum IGF-I concentrations accompanied by reduced growth rates, apparently resulting from increased clearance of systemic IGF-I.
ALS cDNA has been cloned in the human (Leong et al. 1992) , the rat (Dai & Baxter 1992 ) and the baboon (Delhanty & Baxter 1996) and its genomic DNA has been cloned in the mouse (Boisclair et al. 1996) , the rat (Delhanty & Baxter 1997), the human (Suwanichikul et al. 2000) and the sheep (Rhoads et al. 2000) . The ALS gene consists of two exons, flanked by an approximately 1 kb intron, which encode the proximal region of the signal peptide and the rest of the protein, respectively. This gene is expressed primarily in the liver. Hepatic ALS gene expression, as well as plasma ALS concentration, is known to be regulated by somatotropin (Furlanetto 1980 , Baxter & Dai 1994 , Dai et al. 1994 , Ooi et al. 1997 . Although low levels of ALS mRNA are evident in rat and mouse kidneys (Chin et al. 1994 , Ueki et al. 2000 and pig ovaries (Wandji et al. 2000) , no other non-hepatic tissues have been demonstrated to express the ALS gene. It is therefore believed that the ALS protein in any biological fluid is mostly, if not entirely, of hepatic origin (Binoux & Hossenlopp 1988 , Dai & Baxter 1994 , Xu et al. 1995 . In the present communication, we report the nucleotide sequence of a presumptive exon-2 segment of the porcine ALS (pALS) gene encoding the entire mature ALS protein, and we present evidence indicating that the ALS gene is expressed in a number of non-hepatic tissues (albeit at low levels in this species).
MATERIALS AND METHODS

PCR amplification of porcine ALS genomic DNA
PCR primers were designed primarily on the basis of consensus ALS cDNA sequences of the human and the rat, as indicated in Fig. 1a . Primers 665F, 866F and 996R were kindly provided by Dr Y R Boisclair of Cornell University. All of the other primers were synthesized by the DNA Synthesis Core of the Interdisciplinary Center for Biotechnology Research at the University of Florida.
Two hundred nanograms of porcine genomic DNA (Clontech Laboratories, Inc., Palo Alto, CA, USA) were amplified by the PCR (95 C for 5 min then 30 cycles of 95 C for 1 min, 55 C for 1 min and 70 C for 2 min, followed by 70 C for 10 min) using 25 pmol of each primer of the 304F-996R, 665F-305R and 866F-305R pairs in a total volume of 50 µl containing 10% DMSO, 1U high-fidelity Taq polymerase (Boehringer Mannheim, Indianapolis, IN, USA) and 25 nmol nucleoside-5 -triphosphates in 1 Buffer A of the PCR Optimizer Kit (Invitrogen, San Diego, CA, USA; 1 =60 mM Tris-HCl (pH 8·5), 25 mM (NH 4 ) 2 SO 4 and 1·5 mM Mg 2+ ). PCR products were purified using the Wizard DNA Purification Kit (Promega, Madison, WI, USA) followed by ligation into the pCR plasmid vector and transformation into One Shot Escherichia coli cells, using the TA Cloning Kit pCR2·1 (all from Invitrogen) according to the manufacturer's instructions. DNA inserts were sequenced by the dideoxynucleotide chain termination method, using the PCR and vector primers at the DNA Sequencing Core Facility of the University of Florida. Nucleotide sequences were compiled and then compared with known sequences in GenBank, using the  program of the National Center for Biotechnology Information.
Tissue collection
To study the ontogeny of hepatic ALS mRNA expression, day 75 and day 112 pregnant gilts (birth ≅ day 114), one for each day, were slaughtered, after which the whole uteri were removed on to ice; individual fetal livers were dissected as described (Lee et al. 1993 , Green et al. 1996 . Internal organs, including skeletal muscle and reproductive tissues, were excised from cross-bred market pigs and pregnant pigs (gilts) at slaughter at the University of Florida Meat Processing Facility. All of the organ and tissue samples were immersed in liquid nitrogen immediately after dissection and were To examine if hepatic ALS mRNA abundance is increased by somatotropin (ST) in pigs, a total of 10 cross-bred, castrated male pigs (market pigs) each weighing approximately 115 kg were injected intramuscularly with 170 µg porcine ST (pST) (Biotech II Research Institute, LG Chemical Ltd, Taejon, Korea) per kg body weight or vehicle (saline) as previously described (Chung et al. 1985) and slaughtered 2 h after the injection. Blood samples were taken from the jugular vein at the time of injection and at slaughter; liver samples were taken at slaughter and stored frozen in liquid nitrogen and at 80 C. In a second trial, eight market pigs each weighing approximately 100 kg were injected daily with 100 µg pST per kg body weight or vehicle for 7 days. At 6 h after the last injection, the animals were slaughtered and liver samples were excised and stored as above. The doses of pST, which are considered to be physiological to slightly supraphysiological, have been shown, or are expected, to induce a small to a several-fold increase in hepatic IGF-I mRNA abundance (Grant et al. 1991) or in serum IGF-I concentration, with a variable lag time of between 2 and 6 h, presumably depending on the experimental conditions (Etherton et al. 1987, Sillence and Etherton 1987) .
IGF-I radioimmunoassay of serum
Serum IGF-binding proteins were removed by acidic C 18 Sep-Pak (Waters, Milford, MA, USA) chromatography, after which IGF-I radioimmunoassay was performed using a rabbit IGF-I antiserum (Gropep, Adelaide, Australia), basically as described previously (Lee et al. 1991) .
Northern blot analysis
Total RNAs were extracted from the collected tissues either by using TRIzol reagent (Life Technologies, Gaithersburg, MD, USA) or by the method of Puissant & Houdebine (1990) as described previously (Lee et al. 1993 , Choi et al. 1996 . Ten or 30 µg RNA were electrophoresed in a 1·5% agarose/2·2 M formaldehyde gel and transferred to nylon membrane (Biotrans, ICN, Irvine, CA, USA) using the TurboBlotter (Schleicher & Schuell, Keene, NH, USA). After prehybridization, the membrane was hybridized overnight at 42 C with a 32 P-labeled 1158 bp pALS genomic DNA fragment prepared either by nick translation (Lee et al. 1993 , Choi et al. 1996 or by using the random priming method from a commercial kit (Life Technologies). The membrane was washed with 2 SSC/0·1% SDS at room temperature for 30 min, then with 0·1 SSC/0·1% SDS at 55 C for 15-30 min, and then subjected to autoradiography.
Solution hybridization/RNAse protection assay
For the solution hybridization/RNAse protection assay, two or three total RNAs extracted from market-pig tissues were pooled and poly(A) + RNA was enriched by oligo(dT)-cellulose chromatography (Lee et al. 1993) . A 303 bp cDNA for this assay was synthesized by reverse transcription (RT)-PCR. First-strand cDNA was reversetranscribed from the pooled liver poly(A) + RNA preparation (100 ng) using the cDNA Cycle Kit (Invitrogen). PCR (94 C for 2 min, then 35 cycles of 94 C for 1 min, 60 C for 1 min and 72 C for 2 min, followed by 72 C for 10 min) was performed using the 304F-303R primer pair ( Fig. 1 ) and the High-fidelity PCR reagents. The PCR-amplified cDNA fragment was ligated into the pGem-3Z plasmid vector, using EcoRI and BamHI restriction sites that had been placed at the 5 ends of the primers. After EcoRI digestion of the plasmid and gel-purification of the linearized DNA, a 367 nucleotide antisense RNA including a 64 nucleotide vector sequence was transcribed in vitro from 0·5 µg of the purified DNA by using the SP6 promoter for 1 h at 37 C in the presence of 50 µCi [ 32 P]UTP; DNA and free nucleotides were removed by DNAse I digestion and Sephadex G-50 gel chromatography as described previously (Choi et al. 1995) . Five micrograms of the poly(A) + RNA preparation were incubated overnight at 45 C with 4 10 5 c.p.m. of the antisense RNA followed by RNAse treatment, phenol/chloroform extraction, ethanol precipitation, 7·1 M urea/6% polyacrylamide gel electrophoresis, drying and autoradiography.
RESULTS
Cloning of pALS genomic DNA
In rodents, humans and sheep, the ALS gene consists of only two exons encoding the proximal region of the signal peptide and the rest of the ALS protein (Boisclair et al. 1996 , Delhanty & Baxter 1997 , Rhoads et al. 2000 , Suwanichikul et al. 2000 . By using the PCR, with genomic DNA as the template, we have amplified a 915 bp presumptive exon-2 fragment of the pALS gene, encoding the NH 2 -terminal half of the ALS protein, and 1015 bp and 1158 bp overlapping fragments that encode the COOH-terminal half. The 915 bp fragment also includes a short (22 bp) sequence encoding the distal region of the signal peptide. All three fragments share a 155 bp common sequence corresponding to a central region of the ALS cDNA. The compiled sequence of 1775 bp nucleotides from the three overlapping genomic DNA fragments (Fig. 1b) exhibited 84, 79, 79 and 84% identities with respect to those of the corresponding human, rat, mouse and baboon complementary or genomic ALS DNAs respectively. The deduced sequence identities between a mature 583-amino-acid pALS and the above-mentioned species were 81, 77, 78 and 79% respectively. Like the ALS of other known species, the pALS protein contains 20 tandem LRRs (Leong et al. 1992) , including two Leu-X-X-Leu-Leu motifs (Fig. 2a) , which are found in most steroid receptor coactivators (Heery et al. 1997 , McInerney et al. 1998 , in the central domain and also four conserved cysteine residues in the NH 2 -terminal domain (Fig. 2b) . The pALS, like the sheep ALS (Rhoads et al. 2000) , does not contain two proximal cysteine residues conserved in other species in the COOHterminal domain and also has an insertion of one and two amino acids with respect to the primate and rodent ALS proteins respectively (Fig. 2c) .
Hepatic ALS mRNA abundance during development and in response to exogenous ST
Hepatic ALS mRNA abundance was determined by Northern blot analysis using the 1158 bp pALS genomic DNA fragment as a probe. ALS mRNA was barely detectable in the liver at the late mid-fetal stage (day 75; birth ≅ day 114) (Fig. 3a) . By the time of the perinatal stage, a 2·2 kb ALS mRNA was induced, although the relative mRNA abundance at this stage was much less than that in castrated male pigs each weighing approximately 100 kg (market pigs). The hepatic ALS mRNA abundance was not increased at 2 h after a single injection of pST at a moderately supraphysiological dose (170 µg/kg body weight) in market pigs (Fig. 3b) . Consistent with this, serum concentration of IGF-I also was not increased (P>0·05) at two hours after the pST injection; IGF-I concentrations before and after the injection were 119 versus 135 ng/ml and 146 versus 118 ng/ml (with a pooled standard error of 16 ng/ml) for the vehicle-and pST-injected groups respectively. However, when market pigs were injected daily, for 7 days, with pST at a dose of 100 µg/kg body weight and slaughtered 6 h after the last injection, hepatic ALS mRNA abundance was significantly greater in the pST-injected group than in the vehicle-injected group (Fig. 3c) ; serum IGF-I concentrations were not measured in this trial.
ALS mRNA in non-hepatic tissues
The question of whether the ALS gene is expressed in adult non-hepatic tissues was initially examined by Northern blot analysis. The ALS mRNA was detected only in the liver, when various somatic and reproductive tissues from a pig in early pregnancy were examined (Fig. 4) . Northern blot analysis was repeated using poly(A) + RNAs prepared from pigs in early pregnancy and from market pigs, but the ALS transcript was never detected in non-hepatic tissues (data not shown).
Therefore we used a more sensitive solution hybridization/RNAse protection assay to look for the presence of ALS mRNA in non-hepatic tissues. The riboprobe for this assay was transcribed from a linearized pGem-3Z plasmid DNA containing a 303 bp pALS cDNA fragment, the base sequence of which had been confirmed prior to use. After the RNAse protection assay, denaturing polyacrylamide gel electrophoresis and autoradiography, the liver RNA was found to exhibit the most intense 303 bp protected band (Fig. 5) , which was consistent with the previous results of the Northern blot analyses. Unlike the Northern blot method, however, this method also detected a protected band, albeit at reduced intensity, in RNAs from the muscle, ovary, spleen and uterus; in RNAs from the lung, kidney, oviduct and placenta, the protected band was undetectable.
DISCUSSION
We have amplified and cloned, using genomic DNA as a template, three overlapping pALS DNA fragments spanning 1775 nucleotides of a presumptive ALS exon-2 segment coding for the entire  3. Northern blot analysis of hepatic ALS mRNA abundance during development and in response to pST. (a) 10 µg total RNAs extracted from day 75 and day 112 fetal livers (birth ≅ day 114) and castrated male pigs each weighing approximately 100 kg (market pigs) were electrophoresed, transferred to a nylon membrane and hybridized with the 32 P-labeled 1158 bp pALS genomic DNA fragment. The positions of the 28S and 18S rRNAs are indicated on the left of the blot. Shown under the blot are ethidium-bromide-stained 18S rRNAs. (b) Market pigs each weighing approximately 115 kg received a single intramuscular injection of pST (or saline) at a dose of 170 µg/kg body weight, after which liver samples were taken at slaughter 2 h after the injection. Northern blot analysis was performed as in (a). The 2·2 kb ALS mRNA and ethidium-bromidestained 18S rRNAs are shown underneath the blot. The effect of pST on ALS mRNA abundance was not significant (P>0·05); with an arbitrary densitometric unit, means .. were 9·4 2·6 and 15·9 4·2 for the pST-injected and saline-injected groups respectively. (c) Market pigs each weighing approximately 100 kg received a daily intramuscular injection of 100 µg pST (or saline) per kg body weight for 7 days and liver samples were taken 6 h after the last injection. Northern blot analysis was performed as in (a); the 2·2 kb ALS mRNA and ethidium-bromide-stained 18S rRNAs are shown. Means .. of the ALS mRNA band intensity were 36·0 4·7 and 21·9 1·2 for the pST-injected and saline-injected group respectively (P<0·05).
   and others · Porcine acid-labile subunit genemature ALS protein. Initially, we attempted to amplify the entire coding sequence, but these attempts were unsuccessful because of the failure to find any 5 UT primer that annealed to the intended region. We also attempted to screen an unconfirmed commercial gt11 pig-liver cDNA library to clone a full-length ALS cDNA, only to find that the library was just as unreliable.
The approximately 80% identities of the nucleotide and deduced amino acid sequences of the cloned pALS DNA with respect to those of rodents, which were slightly lower than those between the pig and primates, were similar to the reported homology between the primates and rodents (Dai & Baxter 1992 , Boisclair et al. 1996 , Delhanty & Baxter 1996 . Like the known ALS sequences, the deduced pALS also contains the four conserved cysteine residues at identical positions in the NH 2 -terminal domain and the 20 tandem LRRs in the central domain comprising >75% of the protein.
Moreover, detection of the expected size of ALS mRNA in liver RNAs by using a cloned ALS DNA probe also confirms the fidelity of our clones. It is noteworthy that two LXXLL core motifs, which are also called the NR boxes (Heery et al. 1997 , McInerney et al. 1998 , were found to be conserved in the leucine-rich central domain of the ALS protein. This motif is known to facilitate the interaction of different proteins with nuclear receptors, but the function of this motif in the ALS protein is not known. It is also notable that in pALS protein, as in sheep ALS (Rhoads et al. 2000) , two proximal cysteine residues out of the four in the COOH-terminal domain, which are conserved in primates and rodents, are replaced by alanine and arginine. The biochemical consequences of these replacements of conserved cysteine residues deserve future investigation. The perinatal induction and postnatal increase in hepatic ALS mRNA in the pig, which were also noted in sheep (Rhoads et al. 2000) , were similar to previously reported temporal patterns in the ontogeny of the hepatic ST receptor (Breier et al. 1989 , C Y Lee, unpublished observations) and serum concentrations of IGFBP-3 and IGF-I in this species (Lee et al. 1991 (Lee et al. , 1993 . Similarly associated temporal patterns for these components of the ST axis were also reported in the rat, although hepatic ALS mRNA and circulating IGFBP-3 are first detected as late as 3 weeks after birth in this species (Donovan et al. 1989 , Tiong & Herington 1992 , Dai & Baxter 1994 . The pSTinduced increase in hepatic ALS mRNA in market pigs also is at least partially consistent with previously reported results in hypophysectomized rats (Ooi et al. 1997) , although the time-course of pST-induced hepatic ALS gene expression in pituitary-intact pigs needs further investigation. Taken together, the present results regarding the ontogeny of hepatic ALS mRNA and pSTresponsiveness are consistent with the notion that ST is a primary regulator of hepatic ALS gene expression (Zapf et al. 1989 , Dai & Baxter 1994 , Dai et al. 1994 , Ooi et al. 1997 .
The undetectability of ALS mRNA in nonhepatic pig tissues by Northern blot analysis is consistent with previous results reported for other species (Dai et al. 1994 , Delhanty & Baxter 1996 , although Ueki et al. (2000) have recently reported that the ALS mRNA level in the murine kidney was as high as one-sixth of that in the liver. By contrast, the results of the RNAse protection assay indicated that the ALS mRNA was also present in some reproductive and somatic tissues in the pig. In line with this, Wandji et al. (2000) also detected ALS mRNA in pig ovarian follicles by in situ hybridization in which the probe had been synthesized on the basis of our ALS sequence. These results are different from those previously reported for in situ hybridization in the rat (Chin et al. 1994) in which the renal cortex was the only non-hepatic tissue that contained detectable ALS mRNA. The reason(s) for this discrepancy between the results is/are not clear at present, but may reflect a species or methodological difference. In any event, we interpret the present results as indicating that the ALS gene is expressed in some non-hepatic tissues, albeit at low levels.
Apart from the site of ALS gene expression, there are several lines of evidence indicating that ALS protein is present in extravascular fluids. The 150 kDa IGF complexes presumably containing ALS have been detected in porcine colostrum (Simmen et al. 1988) , ovine lymph fluids (Davis et al. 1992) , human skin interstitial fluids (Xu et al. 1995) and synovial fluids (Whellams et al. 2000) . It is noteworthy that the proportion of IGF or IGFBP-3 associated with the presumptive ternary complexes in these fluids is usually less than that in plasma, which is generally interpreted to imply that ALS, by itself or in association with IGFBP-3, somehow traverses the endothelial barrier to the extravascular fluid to a limited extent. The present results, however, suggest that extravascular ALS may also be a product of peripheral tissue(s). On the other hand, the biological function(s) of extravascular ALS is/are only speculative at present. It may modulate the biological action of the IGF, potentially by forming ternary complexes in association with IGFBP-3 or IGFBP-5. In this regard, Twigg et al. (1999) have reported that ALS, which was found in human thyroid connective tissue, potentiated IGFBP-5 inhibition of IGF-Iinduced cell proliferation in human thyroid cell culture. In addition, the possibility of IGF/IGFBPindependent action by ALS, potentially through an interaction with unknown protein(s) by virtue of the LRRs of this protein, cannot be excluded.
In summary, we have amplified, by using a PCR, a pALS genomic DNA segment coding for the entire mature protein, and we have also presented evidence indicating that, although liver is the major organ expressing the ALS gene, some non-hepatic tissues also express the gene at low levels in the pig. More studies are necessary, however, to determine unequivocally the non-hepatic tissues and cell types that express the ALS gene and also to delineate the biological function of locally synthesized ALS protein.
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